 |
 |
 |
|
Mortality risk following HCV cure among people with HCV/HIV co-infection
|
|
|
EASL International Liver Congress, June 23-26, 2021
Janjua NZ 1,2, Wong S 1, Adu PA 1, 2, Abdia Y 1,2, Bartlett S 1,3, Butt ZA 1, Velásquez García HA 1, Makuza JD1,2, Samji H 1,4, Jeong D 1,2, Pearce ME 1,2, Wilton J 1, Alvarez M 1, Binka M 1, Yu A 1, Buller-Taylor T 1, Krajden M 1,3, The BC Hepatitis Testers Cohort Team
1 BC Centre for Disease Control; 2 School of Population and Public Health; 3 Dept. of Pathology and Laboratory Medicine, University of British Columbia; 4 Simon Fraser University, Vancouver, BC, Canada






|
|
|
 |
 |
|
|